Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Opioid manufacturer Insys has filed for bankruptcy — which means it will only pay out a portion of its recent $225 million settlement with the federal government, the Wall Street Journal notes.
Why it matters: Insys executives have been found guilty of bribing doctors to prescribe its painkiller, Subsys, and the legal fallout has now forced the company into bankruptcy. And it's just the tip of the iceberg: State officials still have their sights set on big drug distributors and other manufacturers — most notably Purdue Pharma.